GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xylo Technologies Ltd (NAS:XYLO) » Definitions » Gross Profit
中文

Xylo Technologies (Xylo Technologies) Gross Profit : $11.84 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Xylo Technologies Gross Profit?

Xylo Technologies's gross profit for the six months ended in Dec. 2023 was $3.64 Mil. Xylo Technologies's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was $11.84 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Xylo Technologies's gross profit for the six months ended in Dec. 2023 was $3.64 Mil. Xylo Technologies's Revenue for the six months ended in Dec. 2023 was $38.34 Mil. Therefore, Xylo Technologies's Gross Margin % for the quarter that ended in Dec. 2023 was 9.50%.

Xylo Technologies had a gross margin of 9.50% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

During the past 12 years, the highest Gross Margin % of Xylo Technologies was 67.94%. The lowest was -94.73%. And the median was 14.32%.


Xylo Technologies Gross Profit Historical Data

The historical data trend for Xylo Technologies's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xylo Technologies Gross Profit Chart

Xylo Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.18 -0.50 4.80 14.45 11.84

Xylo Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.20 6.19 8.26 8.20 3.64

Competitive Comparison of Xylo Technologies's Gross Profit

For the Medical Devices subindustry, Xylo Technologies's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xylo Technologies's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xylo Technologies's Gross Profit distribution charts can be found below:

* The bar in red indicates where Xylo Technologies's Gross Profit falls into.



Xylo Technologies Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Xylo Technologies's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=91.724 - 79.883
=11.84

Xylo Technologies's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=38.339 - 34.698
=3.64

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $11.84 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Xylo Technologies's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=3.64 / 38.339
=9.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Xylo Technologies  (NAS:XYLO) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Xylo Technologies had a gross margin of 9.50% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage


Xylo Technologies Gross Profit Related Terms

Thank you for viewing the detailed overview of Xylo Technologies's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Xylo Technologies (Xylo Technologies) Business Description

Traded in Other Exchanges
Address
10 Hanechoshet Street, 4th Floor, Tel Aviv, ISR, 6971072
Medigus Ltd is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incisionless treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company also develops a range of micro video cameras under the micro ScoutCam portfolio of products. It operates in five segments: Medical, E-Commerce, Online, Electric Vehicles, and Corporate. The company's geographical segments include the United States, United Kingdom, Germany, Israel, China, and Others.

Xylo Technologies (Xylo Technologies) Headlines

From GuruFocus

Medigus: Gix Media Increases Holdings in Cortex Media Group to 80% of its Share Capital

By Stock market mentor Stock market mentor 01-26-2023

Medigus: ScoutCam Closes $14 Million Private Placement

By sperokesalga sperokesalga 03-21-2023